Biol stock forecast.

Find the latest Leap Therapeutics, Inc. (LPTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Nov 13, 2023 · High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year. A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...

Nov 21, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38 . Today 200 Day Moving Average is the resistance level ( 15.93 $). BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 22.25 . Today 200 Day Moving Average is the resistance level ( 17.28 $).SYN Stock 12 Months Forecast. $4.00. (292.16% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Synthetic Biologics in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 292.16% change from the last price of $1.02.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

CEO. Website. 1984. 190. John Beaver. https://www.biolase.com. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists ...Nov 30, 2023 · BIOL's stock price has decreased by -98.87% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 3 stock analysts, the average 12-month stock price forecast for BIOLASE stock is $113.33, which predicts an increase of 9,929.20%. Find the latest Gossamer Bio, Inc. (GOSS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company also offers consumable products, teeth whitening kits, and earnings reports.Biolase Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction. ... BIOL Related stocks. Symbol 3M %Chg ; BIOL -78.14% : Biolase Inc: BDX -14.11% ...

Compare the performance and outlook of top stocks in the pharmaceutical sector. Russell 2000 Stocks Learn more about the 2000 stocks that make up this small-cap index and why you might want to invest in them. Search All Stocks . Popular Stocks. Company Price; AAPL. Apple Inc. $191.24 0.68%: MSFT. Microsoft Co. $374.51-1.16%: …

Stock Forecast Currrency forecast Cryptocurrency forecast Blog All stock predictions Overall outlook for BIOLASE stock Tomorrow Week Month 2023 2024 2025 2026 2027 …

Looking at the chart of Biolase Inc. (BIOL Stock Forecast), we can see a starkly different trend in comparison to the AMPE stock chart. Sure, this year has been relatively flat. But pull out a 2-year chart and you’ll see that BIOL stock has been in a perpetual downtrend since last March.Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsNov 21, 2023 · Target values for the price of one BIOLASE share for Aug 2024. The weighted average target price per BIOLASE share in Aug 2024 is: 1.67. In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.327% volatility is expected. Pessimistic target level: 1.51. Optimistic target level: 1.77. BIOL Stock Analysis Overview What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of …The BIOLASE stock forecast for tomorrow is $ 1.153103, which would represent a 1.15% gain compared to the current price. In the next week, the price of BIOL is expected to increase by 5.97% and hit $ 1.208013. As far as the long-term BIOLASE stock forecast is concerned, here’s what our ...

16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.Dec 1, 2023 · Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ... For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ...Nov 27, 2023 · CEO. Website. 1984. 190. John Beaver. https://www.biolase.com. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists ... BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit. The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.

Bluebird Bio. Market Cap. $466M. Today's Change. (11.52%) $0.44. Current Price. $4.26. Price as of December 1, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ...Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all ...

2024 STOCK MARKET OUTLOOK. For the third quarter, ended Sept. 30, 2021, BIOL’s net revenue increased 45.8% year-over-year to $9.53 million. The company’s laser system sales increased 64% year-over-year, while its consumables and other revenue increased 21% year-over-year. However, its net loss came in at $3.28 million versus $12,000 in ...Customizable Real Time Market Alerts. Stock forecast As of 2022 April 22 Friday current price of BIOL stock is 03047 and our data indicates that the asset price has been in a downtrend for the. BIOLASE Stock Forecast 06-15-2022. BIOL stock forecast and price target. How to buy Biolase.Stock Forecast Currrency forecast Cryptocurrency forecast Blog All stock predictions Overall outlook for BIOLASE stock Tomorrow Week Month 2023 2024 2025 2026 2027 …For Surface Oncology stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Surface Oncology stock forecast of $1.13, a high forecast of $1.13, and a low forecast of $1.13. The average Surface Oncology stock forecast 2023 represents a 5.47% increase from the last price of $1.07000005245209.Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...morningstar.com - November 1 at 12:25 PM. BIOLASE, Inc. (BIOL) ca.finance.yahoo.com - October 18 at 8:14 AM. BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. finance.yahoo.com - September 18 at 5:11 PM.Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...

Gevo’s Q1 2023 earnings report showed total revenue of just $4.1 million dollars. Cost of revenue was $4.4 million dollars, so Gevo is forced to sell its product for less than it costs to make ...

Jan 5, 2022 · 2024 STOCK MARKET OUTLOOK. For the third quarter, ended Sept. 30, 2021, BIOL’s net revenue increased 45.8% year-over-year to $9.53 million. The company’s laser system sales increased 64% year-over-year, while its consumables and other revenue increased 21% year-over-year. However, its net loss came in at $3.28 million versus $12,000 in ...

Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates. Find the latest First Wave BioPharma, Inc. (FWBI) stock quote, history, news and other vital information to help you with your stock trading and investing.How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.24 per share, the total value of Biolase stock (market capitalization) is $2.85M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.For X4 Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average X4 Pharmaceuticals stock forecast of $0.6, a high forecast of $0.75, and a low forecast of $0.5. The average X4 Pharmaceuticals stock forecast 2024 represents a -25.05% decrease from the last price of $0.800599992275238.Oct 26, 2023 · Unraveling BIOLASE (BIOL) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing BIOLASE and its promising trajectory, we have meticulously collated insights from various analyst forecasts. The Biolase Inc ( BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1639.46% increase from …Nov 21, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38 . Today 200 Day Moving Average is the resistance level ( 15.93 $).

Starting us off today is Twist Biosciences. In brief, Twist is a leading name in the synthetic biology industry today. The company’s core work revolves around its proprietary DNA synthesis ...About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Biolase stock price has been showing a declining tendency so we believe that similar market segments were not very …Find the latest Red White & Bloom Brands Inc. (RWBYF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Instagram:https://instagram. eusohbest s p 500 index fundsbooking.com stockwebull cash vs margin account I'm Mike Wilson, Chief Investment Officer and Chief U.S. Equity Strategist for Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the latest trends in the financial marketplace. It's Monday, November 6th, at 10 a.m. in New York. So let's get after it. With many stocks down more than 20% from ... reality stockbest medical insurance nyc Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 3.29B. -13.94%. Get the latest Roche Holding AG (RO) real-time quote, historical ...How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. venture capital vs investment banking BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes. Experience the BIOLASE difference and discover the limitless potential of laser dentistry. Dentists.4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).